Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Small intestinal bacterial overgrowth (SIBO) is a condition in which excessive levels of bacteria, mainly the colonic-type species are present in the small intestine. Recent data suggest that SIBO may contribute to the pathophysiology of Irritable bowel syndrome (IBS). The purpose of this study was to identify potential predictors of SIBO in patients with IBS. Methods: Adults with IBS based on Rome II criteria who had predominance of bloating and flatulence underwent a glucose breath test (GBT) to determine the presence of SIBO. Breath samples were obtained at baseline and at 30, 45, 60, 75 and 90 minutes after ingestion of 50 g of glucose dissolved in 150 mL of water. Results of the glucose breath test, which measures hydrogen and methane levels in the breath, were considered positive for SIBO if 1) the hydrogen or methane peak was >20 ppm when the baseline was <10 ppm, or 2) the hydrogen or methane peak increased by 12 ppm when baseline was ≥10 ppm. Results: Ninety-eight patients were identified who underwent a GBT (mean age, 49 y; 78% female). Thirty-five patients (36%) had a positive GBT result suggestive of SIBO. A positive GBT result was more likely in patients >55 years of age (odds ratio [OR], 3.6; 95% confidence interval [CI], 1.4-9.0) and in females (OR, 4.0; 95% CI, 1.1-14.5). Hydrogen was detected more frequently in patients with diarrhea-predominant IBS (OR, 8; 95% CI, 1.4-45), and methane was the main gas detected in patients with constipation-predominant IBS (OR, 8; 95% CI, 1.3-44). There was no significant correlation between the presence of SIBO and the predominant bowel pattern or concurrent use of tegaserod, proton pump inhibitors, or opiate analgesics. Conclusions: Small intestinal bacterial overgrowth was present in a sizeable percentage of patients with IBS with predominance of bloating and flatulence. Older age and female sex were predictors of SIBO in patients with IBS. Identification of possible predictors of SIBO in patients with IBS could aid in the development of successful treatment plans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“Symptoms of IBS can substantially impact patients’ quality of life, and the effect of IBS on physical and psychological health can negatively impact the workplace [ 3-5 ].”
BackgroundEradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780 · cited 5×
“In studies using lactulose or glucose breath testing, SIBO was detected in up to 84% (Range 4-84%) of patients who met Rome I [15,17] or Rome II [13,14,16] criteria for IBS.”
BackgroundResultInfluentialSmall intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud, I., Stotzer, P.-O., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2007) · Gut · doi:10.1136/gut.2006.108712 · Cited by 499 · cited 2×
“The most accurate method for detecting SIBO is the subject of much debate [10,12,26]; however, results from clinical studies evaluating SIBO in IBS have confirmed the presence of SIBO in a subset of patients with IBS.”
MethodResultSmall Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome
Lin, H. C. (2004) · JAMA · doi:10.1001/jama.292.7.852 · Cited by 396 · cited 3×
“Because breath tests indirectly measure bacteria and are associated with relatively low sensitivity and specificity [10], many consider direct bacterial assessment of intestinal aspirate cultures a better method of detecting SIBO [8,9,25].”
BackgroundMethodSharara, A. I., Aoun, E., Abdul-Baki, H., Mounzer, R., Sidani, S., & ElHajj, I. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00458.x · Cited by 344 · cited 2×
“Furthermore, results from multiple clinical studies have shown that treatment with antibiotics can reduce or eradicate SIBO [14,15,17-22] and improve symptoms of IBS [15,17,18,21-24], evidence that further supports the role of SIBO in IBS.”
ResultThe Burden of Illness of Irritable Bowel Syndrome: Current Challenges and Hope for the Future
Hulisz, D. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.4.299 · Cited by 215 · cited 1×
“7 to $10 billion annually and estimated indirect costs (eg, employee absenteeism) of up to $20 billion annually [7].”
Background
Cited by
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 997
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Lo, W., & Chan, W. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.011 · Cited by 353
Recent advances in hydrogen research as a therapeutic medical gas
Huang, C.-S., Kawamura, T., Toyoda, Y., & Nakao, A. (2010) · Free Radical Research · doi:10.3109/10715762.2010.500328 · Cited by 331
Potential Role of the Microbiome in Acne: A Comprehensive Review
Lee, Y. B., Byun, E. J., & Kim, H. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070987 · Cited by 316
Methanogens, Methane and Gastrointestinal Motility
Triantafyllou, K., Chang, C., & Pimentel, M. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2014.20.1.31 · Cited by 254
“0), using glucose breath testing.(64) The results of these”
Method
Metadata
- Authors
- Reddymasu, S. C., Sostarich, S., & McCallum, R. W.
- Venue
- BMC Gastroenterology
- Published
- 2010-02-22
- Volume
- 10
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1471-230X (ISSN-L)
- OpenAlex
- W2138321678
- Cited by
- 74
- References
- 8
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? https://app.cochat.ai/papers/10.1186/1471-230x-10-23
- The paper
- Reddymasu, S. C., Sostarich, S., & McCallum, R. W. (2010). Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterology. https://doi.org/10.1186/1471-230x-10-23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.